Eli Lilly Will Buy a Narcolepsy Drug Developer for $6.3 Billion
✨ AI Summary
🔊 جاري الاستماع
Eli Lilly plans to acquire Centessa Pharmaceuticals, which has been conducting a midstage clinical trial of its lead drug.




